Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Reported Late Friday, Biomerica Q3 EPS $(0.11) Up From $(0.12) YoY, Sales $1.02M Down From $1.11M YoY

Author: Benzinga Newsdesk | April 15, 2024 02:20am
Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.11) per share. This is a 8.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported $1.02 million in sales this quarter. This is a 8.46 percent decrease over sales of $1.11 million the same period last year.

Posted In: BMRA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist